Literature DB >> 16831303

Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus.

M Martinetti1, I Pacati, M Cuccia, C Badulli, A Pasi, L Salvaneschi, E Minola, A De Silvestri, A M Iannone, A Maccabruni.   

Abstract

Mother-to-infant transmission of Hepatitis C Virus (HCV) represents the major cause of pediatric HCV infection today. Immunogenetic influence has been poorly investigated and mainly confined to HLA-class II serological polymorphisms. Among 290 parities, 135 from Pavia and 155 from Bergamo, of HCV-RNA-infected Italian women, 21 babies (7.24%) were HCV-RNA positive at birth and steadily positive over 20 months of life. All the 21 infected babies and 44 randomly selected uninfected ones, born to HCV-RNA+ mothers but steadily negative for HCV-RNA during a follow-up of 2 years, and their mothers were investigated for HLA-G, -C, -DRB1, -DQA1 and -DQB1 genomic polymorphisms. Among the different covariates, HLA-Cw*07, -G*010401, -DRB1*0701, -DRB1*1401 and homozygosity for HLA-G 14bp deletion can be considered as risk factors for HCV vertical transmission. On the contrary, protection was conferred by the HLA-DQB1*06, -G*0105N, -Cw*0602, DRB1*1104 and -DRB1*1302 alleles. Our initial question was: has the immunogenetic profile any role in the protection of the fetus growing in an infected milieu and, if so, is it independent from the other non-immunogenetic parameters? The answer to both questions should be yes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831303     DOI: 10.1177/039463200601900213

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  13 in total

Review 1.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 2.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

3.  HLA-G 14 bp deletion/insertion polymorphism and mother-to-child transmission of HIV.

Authors:  L Segat; L Zupin; H-Y Kim; E Catamo; D M Thea; C Kankasa; G M Aldrovandi; L Kuhn; S Crovella
Journal:  Tissue Antigens       Date:  2014-03

4.  Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.

Authors:  Ivo Ivić; Nikola Bradarić; Neira Puizina-Ivić; Dragan Ledina; Boris Luksić; Roko Martinić
Journal:  Croat Med J       Date:  2007-12       Impact factor: 1.351

Review 5.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 6.  Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.

Authors:  Pier-Angelo Tovo; Carmelina Calitri; Carlo Scolfaro; Clara Gabiano; Silvia Garazzino
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 7.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

8.  Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population.

Authors:  Ming Yue; Ke Xu; Meng-Ping Wu; Ya-Ping Han; Peng Huang; Zhi-Hang Peng; Jie Wang; Jing Su; Rong-Bin Yu; Jun Li; Yun Zhang
Journal:  Int J Mol Sci       Date:  2015-07-23       Impact factor: 5.923

Review 9.  Immunomodulatory properties of HLA-G in infectious diseases.

Authors:  Laurence Amiot; Nicolas Vu; Michel Samson
Journal:  J Immunol Res       Date:  2014-04-15       Impact factor: 4.818

10.  Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients.

Authors:  Serkan Ocal; Haldun Selcuk; Murat Korkmaz; Reskan Altun; Abdullah E Yildirim; Enver Akbas
Journal:  Saudi J Gastroenterol       Date:  2014 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.